The 150 most important questions in cancer research and clinical oncology series: questions 31–39
Author:
Publisher
Springer Science and Business Media LLC
Subject
Oncology
Link
http://link.springer.com/content/pdf/10.1186/s40880-017-0215-6.pdf
Reference6 articles.
1. Qian CN, Zhang W, Xu RH. Defeating cancer: the 150 most important questions in cancer research and clinical oncology. Chin J Cancer. 2016;35(1):104.
2. Wee JT, Poh SS. The most important questions in cancer research and clinical oncology: question 1. Could the vertical transmission of human papilloma virus (HPV) infection account for the cause, characteristics, and epidemiology of HPV-positive oropharyngeal carcinoma, non-smoking East Asian female lung adenocarcinoma, and/or East Asian triple-negative breast carcinoma? Chin J Cancer. 2017;36(1):13.
3. Venniyoor A. The most important questions in cancer research and clinical oncology: question 2–5. Obesity-related cancers: more questions than answers. Chin J Cancer. 2017;36(1):18.
4. Chinese Journal of Cancer. The most important questions in cancer research and clinical oncology series: question 6–14. Chin J Cancer. 2017;36:33.
5. Chinese Journal of Cancer. The most important questions in cancer research and clinical oncology series: question 15–24. Chin J Cancer. 2017;36:39.
Cited by 11 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Revisiting and proposing the most important questions in cancer research and clinical oncology;Visualized Cancer Medicine;2024
2. The 150 most important questions in cancer research and clinical oncology series: questions 102–104;Visualized Cancer Medicine;2024
3. The changing landscape of phase II/III metastatic sarcoma clinical trials—analysis of ClinicalTrials.gov;BMC Cancer;2018-12
4. The 150 most important questions in cancer research and clinical oncology series: questions 94-101;Cancer Communications;2018-11-26
5. Prognostic value of the fibrinogen/albumin ratio (FAR) in patients with operable soft tissue sarcoma;BMC Cancer;2018-10-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3